Insights

NHS-focused value Daiichi Sankyo UK emphasizes delivering innovative medicines to support the NHS in sustainable, high-quality care, opening sales opportunities around cardiovascular and oncology therapies that align with NHS efficiency and patient access goals.

Digital health partnerships Recent strategic collaborations in digital health for remote atrial fibrillation detection indicate openness to digital health solutions, data-enabled patient care, and potential cross-sell of digital diagnostics, monitoring, and integration services.

Mid-market footprint With 51-200 employees and revenue in the lower-mid single digits to mid tens of millions, there is a clear niche for scalable partnerships, managed services, and cost-effective clinical programs tailored for mid-size pharma collaborations and NHS procurement needs.

Technology readiness Adoption of enterprise tools such as SAP, Microsoft 365, OneTrust, and DocuSign suggests readiness for integrated operations, regulatory compliance, and streamlined vendor management—opportunities to offer compliant IT, data, and workflow optimization solutions.

Strategic growth signals Historical merger lineage and a mission to address unmet medical needs, combined with recent external health tech partnerships, indicate potential for co-development, joint ventures, or distribution partnerships in cardiovascular and oncology portfolios.

Similar companies to Daiichi Sankyo UK

Shire UK
48$1M - $10M
Novartis UK
335$25M - $50M

Daiichi Sankyo UK Tech Stack

Daiichi Sankyo UK uses 8 technology products and services including Google Ads, iCIMS, AutoCAD, and more. Explore Daiichi Sankyo UK's tech stack below.

Google Ads
Advertising
iCIMS
Applicant Tracking Systems
AutoCAD
Cad & Graphics
OneTrust
Cookie Compliance
SAP
Customer Relationship Management
Microsoft 365
Email
DocuSign
Miscellaneous
Miro
Team Collaboration

Media & News

Daiichi Sankyo UK's Email Address Formats

Daiichi Sankyo UK uses at least 4 email formats:

Daiichi Sankyo UK Email Formats	Example	Percentage
First.Last@daiichi-sankyo.co.uk	John.Doe@daiichi-sankyo.co.uk	66%
FLast@daiichi-sankyo.co.uk	JDoe@daiichi-sankyo.co.uk	26%
First@daiichi-sankyo.co.uk	John@daiichi-sankyo.co.uk	5%
FirstLast@daiichi-sankyo.co.uk	JohnDoe@daiichi-sankyo.co.uk	3%

Frequently Asked Questions

What is Daiichi Sankyo UK's official website and social media links?

Daiichi Sankyo UK's official website is daiichi-sankyo.co.uk and has social profiles on LinkedIn.

How much revenue does Daiichi Sankyo UK generate?

As of August 2026, Daiichi Sankyo UK's annual revenue is estimated to be $10M - $25M.

What is Daiichi Sankyo UK's NAICS code?

Daiichi Sankyo UK's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Daiichi Sankyo UK have currently?

As of August 2026, Daiichi Sankyo UK has approximately 161 employees across 2 continents, including Europe and North America. Key team members include Head Of Evidence Generation Data Management: V. J., Head Of Supply: N. G. and Head Of Finance: S. S. Explore Daiichi Sankyo UK's employee directory with LeadIQ.

What industry does Daiichi Sankyo UK belong to?

Daiichi Sankyo UK operates in the Pharmaceutical Manufacturing industry.

What technology does Daiichi Sankyo UK use?

Daiichi Sankyo UK's tech stack includes Google Ads, iCIMS, AutoCAD, OneTrust, SAP, Microsoft 365, DocuSign and Miro.

What is Daiichi Sankyo UK's email format?

Daiichi Sankyo UK's email format typically follows the pattern of First.Last@daiichi-sankyo.co.uk. Find more Daiichi Sankyo UK email formats with LeadIQ.

When was Daiichi Sankyo UK founded?

Daiichi Sankyo UK was founded in 2006.

Daiichi Sankyo UK

Q: How many employees does Daiichi Sankyo UK have currently?

Daiichi Sankyo UK has approximately 161 employees.

Q: What technology does Daiichi Sankyo UK use?

Daiichi Sankyo UK's tech stack includes Apache HTTP Server, LinkedIn Learning, R Project, IQVIA, Qlik.

Q: What is Daiichi Sankyo UK's NAICS code?

Daiichi Sankyo UK's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingEngland, United Kingdom51-200 Employees

Daiichi Sankyo UK is a mid-sized pharmaceutical manufacturing company based in Uxbridge, in the Greater London region. It operates as the UK arm of a Japan-origin group with a scientific heritage spanning more than a century, and it was founded in 2006 through the European merger of Daiichi and Sankyo. The company focuses on developing and supplying medicines to support the NHS, particularly in cardiovascular disease and oncology. Its work centers on discovering and delivering innovative medicines that address diverse and unmet medical needs, with an emphasis on delivering value and sustainable, high-quality care for patients. A notable recent development is a 2021 collaboration to offer a digital health solution in the UK for remote detection and diagnosis of atrial fibrillation, illustrating its engagement with health-tech partnerships to extend care within the NHS.